Established in 2020 Wednesday, March 27, 2024


BioNTech boosts 2021 vaccine supply forecast to 2 bn doses
A health worker holds a vial with the Pfizer-BioNTech COVID-19 vaccine against the novel coronavirus at the vaccination center in Pfaffenhofen, southern Germany, on January 10, 2021. Christof Stache / AFP.



FRANKFURT AM MAIN (AFP).- German company BioNTech, which developed the first coronavirus vaccine approved in the West, said Monday it expects to produce two billion doses in 2021, up from the 1.3 billion previously forecast.

"We now believe that we can potentially deliver approximately 2 billion doses in total by the end of 2021, which incorporates the updated six-dose label," said the company, referring to an additional dose that could be extracted from each vial of the vaccine.

European regulators last week approved doctors drawing six doses from each vial, boosting dosage capacity by 20 percent.

The Mainz-based company, which developed the jab with US giant Pfizer, is planning to open a new factory in Marburg, Germany, in February, expected to ramp up production capacity by 750 million doses a year.

The site will join five other sites in Germany, Belgium and the US shared with Pfizer.




The company said it had shipped nearly 33 million doses by January 10, more than a month after Britain became the first Western nation to approve any vaccine on December 2.

BioNTech's announcement comes after the EU agreed to raise its orders of the vaccine by 200 million doses, with an option for another 100 million.

But the vaccination rollout has been criticised across Europe, with sluggish starts in nations like France and the Netherlands.

The company added that Covid-19 will "likely become an endemic disease", and that vaccines would need to fight against the emergence of new viral variants and a "naturally waning immune response".

The German company said last week that studies show its vaccine works against the new mutation found in variants uncovered in Britain and South Africa.

© Agence France-Presse







Today's News

January 12, 2021

Tasmanian tiger pups found to be extraordinarily similar to wolf pups

BioNTech boosts 2021 vaccine supply forecast to 2 bn doses

Rice 'flashes' new 2D materials

Boosting solar energy conversion efficiency

Research explains why crocodiles have changed so little since the age of the dinosaurs

Sniffing out an abrupt COVID-19 symptom

Despite vaccines, no Covid herd immunity in 2021: WHO

WHO says China mission not playing blame game

Delft researchers build artificial chromosome

Carbon monoxide reduced to valuable chemical

Frozen egg wastage prompts calls for women to donate unused eggs

Breakthrough research heralds a new diamond age

Online collaborative platforms lead to advances in archaeological survey of the Andes

Unique study incorporates fluid dynamics and more to evaluate, enhance future implants

2D compound shows unique versatility

Tulane scientist honored for research on reproductive health

New process more efficiently recycles excess CO2 into fuel, study finds

More management measures lead to healthier fish populations



 


Editor & Publisher: Jose Villarreal
Art Director: Juan José Sepúlveda Ramírez



Tell a Friend
Dear User, please complete the form below in order to recommend the ResearchNews newsletter to someone you know.
Please complete all fields marked *.
Sending Mail
Sending Successful